Article info
Case report
COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?
- Correspondence to Dr Shweta Mallikarjun Revannavar; shweta.connect2{at}gmail.com
Citation
COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?
Publication history
- Accepted April 15, 2021
- First published April 27, 2021.
Online issue publication
April 27, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage